This study is the first large series investigating human mucin gene expression in the kidney. MUC1, MUC3 and MUC6 are expressed in normal and tumour kidney. The over-expression of MUC3 in renal cell carcinomas favours its implication in renal tumorigenesis.
Colonic mucosal protection is provided by the mucus gel, mainly
composed of mucins. Several factors can modulate the formation
and the secretion of mucins, and among them butyrate, an endproduct of carbohydrate fermentation. However, the specific
effect of butyrate on the various colonic mucins, and the
consequences in terms of the mucus layer thickness are not
known. Our aim was to determine whether butyrate modulates
colonic MUC genes expression in vivo and whether this results in
changes in mucus synthesis and mucus layer thickness. Mice
received daily for 7 days rectal enemas of butyrate (100 mM)
versus saline. We demonstrated that butyrate stimulated the
gene expression of both secreted (Muc2) and membrane-linked
(Muc1, Muc3, Muc4) mucins. Butyrate especially induced a 6-fold
increase in Muc2 gene expression in proximal colon. However,
butyrate enemas did not modify the number of epithelial cells
containing the protein Muc2, and caused a 2-fold decrease in the
thickness of adherent mucus layer. Further studies should help
understanding whether this last phenomenon, i.e. the decrease
in adherent mucus gel thickness, results in a diminished
protective function or not.
Background:Microsatellite instability (MSI) is a molecular phenotype due to defective DNA mismatch repair (MMR) system. It is used to predict outcome of colorectal tumours and to screen tumours for Lynch syndrome (LS). A pentaplex panel composed of five mononucleotide markers has been largely recommended for determination of the MSI status. However, its sensitivity may be taken in default in occasional situations. The aim of the study was to optimise this panel for the detection of MSI.Methods:We developed an assay allowing co-amplification of six mononucleotide repeat markers (BAT25, BAT26, BAT40, NR21, NR22, NR27) and one polymorphic dinucleotide marker (D3S1260) in a single reaction. Performances of the new panel were evaluated on a cohort of patients suspected of LS.Results:We demonstrate that our assay is technically as easy to use as the pentaplex assay. The hexaplex panel shows similar performances for the identification of colorectal and non-MSH6-deficient tumours. On the other hand, the hexaplex panel has higher sensitivity for the identification of MSH6-deficient tumours (94.7% vs 84.2%) and MMR-deficient tumours other than colorectal cancer (92.9% vs 85.7%).Conclusion:The hexaplex panel could thus be an attractive alternative to the pentaplex panel for the identification of patients with LS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.